Intelligent Financial Systems selected Activ Financial's US equity market data to drive research and analytics for its LiquidMetrix Workstation product suite and new coverage of North American markets.
Today, Activ Financial announced that IFS - a London-based research and market data analysis company - is tapping into the firm's US equities market data to power its transaction cost analysis.
Clients will be able to use the LiquidMetrix WorkStation to analyze the performance of their trade flows on North American markets for best execution and TCA with millisecond precision. The company already provides pre-and post-trade analytics on European markets through its LiquidMetrix products. The partnership with Activ will enable cleitns to rollout LiquidMetrix services on a wider geographic basis, stated the company.
"Strong data is the key to driving research and analytics making partnering with a leading provider a core component of our expansion into North America," stated Sabine Toulson, managing director at IFS. Our clients come to us for precise and accurate benchmarking information and Activ was an obvious choice to supply the US equity market data considering their position in the US market."
Since the implementation of MiFID in 2007, IFS has developed a suite of services under the LiquidMetrix brand focused on transaction cost analysis, best Execution compliance and pre-trade cost prediction for Europe's increasingly fragmented equity markets. Since 2009, IFS has offered these services through the LiquidMetrix WorkStation Terminal.
Activ Financal is a global provider of fully managed low-latency and enterprise market data solutions serving over 400 customers worldwide, managing more than 120 feed handlers and nearly 20 data centers spread across five continents. Ivy is Editor-at-Large for Advanced Trading and Wall Street & Technology. Ivy is responsible for writing in-depth feature articles, daily blogs and news articles with a focus on automated trading in the capital markets. As an industry expert, Ivy has reported on a myriad ... View Full Bio